Researchers have found a new way to reactivate fetal hemoglobin without the need for gene-editing therapy, according to a new study.

Disc Medicine will be enrolling 24 adults with SCD in its newly launched trial testing DISC-3405 at three doses for easing ...

Columnist Oluwatosin Adesoye encourages medical professional to be more mindful about the care they provide to sickle cell ...

Although she understands her illness, columnist Michelle Harlan is still learning how to communicate and disclose her sickle ...

Sickle cell disease (SCD) is an inherited disorder caused by a mutation in the gene encoding a subunit of hemoglobin, the protein that carries oxygen in red blood cells. Mutant hemoglobin — called ...

Sickle cell disease is an inherited disorder that affects red blood cells. People with the disease produce a faulty version of hemoglobin — the protein that carries oxygen throughout the body.

Sickle cell anemia is an inherited blood disorder. It is caused by a mutation in the gene encoding for hemoglobin, the protein in red blood cells that binds to oxygen so it can be transported ...

Sickle cell anemia is caused by a mutation in the HBB gene which provides the instructions to make part of hemoglobin, the protein in red blood cells that carries oxygen. Researchers are working on ...

Sickle cell anemia is an inherited disease that is caused by an abnormal version of hemoglobin, known as hemoglobin S or sickle hemoglobin. Patients with the disease often experience acute or chronic ...

Sickle cell disease (SCD) may be cured in some individuals by a stem cell transplant. There also are several approved therapies to help manage the condition and its related complications. Some of the ...

What is Casgevy for sickle cell disease? Casgevy (exagamglogene autotemcel), formerly known as CTX001 or exa-cel, is an approved gene-editing therapy used for people with sickle cell disease (SCD) who ...